for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Tabula Rasa HealthCare Inc

TRHC.OQ

現在値

57.30USD

変化

--(--)

本日のレンジ

--

 - 

--

52週レンジ

33.50

 - 

69.72

∙ 約20分前の相場を表示しています。

適時開示

Tabula Rasa Healthcare Reports Q1 Adjusted Non-GAAP Earnings Per Share $0.01

May 7 (Reuters) - Tabula Rasa HealthCare Inc <TRHC.O>::TABULA RASA HEALTHCARE REPORTS FIRST QUARTER 2020 RESULTS.Q1 ADJUSTED NON-GAAP EARNINGS PER SHARE $0.01.Q1 EARNINGS PER SHARE ESTIMATE $-0.05 -- REFINITIV IBES DATA.Q1 LOSS PER SHARE $0.68.SEES Q2 2020 REVENUE $76 MILLION TO $81 MILLION.Q1 REVENUE $72.8 MILLION VERSUS REFINITIV IBES ESTIMATE OF $71.8 MILLION.SEES Q2 GAAP NET LOSS IN RANGE OF $12.3 MILLION TO $10.8 MILLION.SEES Q2 NON-GAAP ADJUSTED EBITDA IN RANGE OF $7 MILLION TO $9 MILLION.SEES FY 2020 REVENUE IN RANGE OF $332 MILLION TO $352 MILLION.SEES FY 2020 GAAP NET LOSS IN RANGE OF $35.5 MILLION TO $30.5 MILLION.SEES FY 2020 NON-GAAP ADJUSTED EBITDA IN RANGE OF $46 MILLION TO $52 MILLION.Q2 REVENUE VIEW $83.3 MILLION -- REFINITIV IBES DATA.FY2020 REVENUE VIEW $339.5 MILLION -- REFINITIV IBES DATA.

Tabula Rasa Healthcare Inc Announces Expanded Laboratory Services Agreement With Cquentia

April 16 (Reuters) - Tabula Rasa HealthCare Inc <TRHC.O>::TABULA RASA HEALTHCARE INC - ANNOUNCED AN EXPANDED LABORATORY SERVICES AGREEMENT WITH CQUENTIA.TABULA RASA HEALTHCARE® AND CQUENTIA® EXPAND PARTNERSHIP WITH COVID-19 TEST KIT DISTRIBUTION AGREEMENT.TABULA RASA HEALTHCARE INC - AGREEMENT PROVIDES TRHC WITH ACCESS TO COVID-19 (SARS-COV-2 RNA) TESTING KITS.

Tabula Rasa HealthCare Announces Fourth Quarter And Full Year 2019 Results

Feb 27 (Reuters) - Tabula Rasa HealthCare Inc <TRHC.O>::TABULA RASA HEALTHCARE ANNOUNCES FOURTH QUARTER AND FULL YEAR 2019 RESULTS.Q4 ADJUSTED EARNINGS PER SHARE $0.13.Q4 LOSS PER SHARE $0.33.Q4 REVENUE $73.2 MILLION VERSUS REFINITIV IBES ESTIMATE OF $72.7 MILLION.Q4 EARNINGS PER SHARE ESTIMATE $0.04 -- REFINITIV IBES DATA.REVENUE FOR Q1 OF 2020 ENDING ON MARCH 31 IS EXPECTED TO BE IN RANGE OF $68.5 MILLION TO $73.5 MILLION.Q1 2020 NET LOSS IS EXPECTED TO BE IN RANGE OF $13.2 MILLION TO $12.5 MILLION.REVENUE FOR FULL FISCAL YEAR 2020 ENDING ON DECEMBER 31 IS EXPECTED TO BE IN RANGE OF $332 MILLION TO $352 MILLION.FULL YEAR 2020 NET LOSS IS EXPECTED IN RANGE OF $31 MILLION TO $27 MILLION.FULL YEAR 2020 NON-GAAP ADJUSTED EBITDA IS EXPECTED TO BE IN RANGE OF $46 MILLION TO $52 MILLION.Q1 EARNINGS PER SHARE VIEW $0.08, REVENUE VIEW $76.6 MILLION -- REFINITIV IBES DATA.FY2020 EARNINGS PER SHARE VIEW $0.92, REVENUE VIEW $343.2 MILLION -- REFINITIV IBES DATA.

Tabula Rasa Healthcare Posts Q3 Loss Per Share Of $0.39

Nov 7 (Reuters) - Tabula Rasa HealthCare Inc <TRHC.O>::TABULA RASA HEALTHCARE ANNOUNCES THIRD QUARTER 2019 OPERATING RESULTS.Q3 LOSS PER SHARE $0.39.Q3 REVENUE $74.3 MILLION VERSUS REFINITIV IBES ESTIMATE OF $75.5 MILLION.Q3 EARNINGS PER SHARE ESTIMATE $0.17 -- REFINITIV IBES DATA.Q3 ADJUSTED EARNINGS PER SHARE $0.22.SEES FY 2019 REVENUE $282 MILLION TO $285 MILLION.QTRLY ADJUSTED EARNINGS PER SHARE $0.22.REVENUE FOR FISCAL YEAR 2019 IS NOW EXPECTED TO BE IN RANGE OF $282.0 MILLION TO $285.0 MILLION.EXPECTS FY 2019 NET LOSS IN RANGE OF $37.7 MILLION TO $36.8 MILLION.

Tabula Rasa Healthcare Q2 Loss Per Share $0.32

Aug 8 (Reuters) - Tabula Rasa HealthCare Inc <TRHC.O>::TABULA RASA HEALTHCARE ANNOUNCES SECOND QUARTER 2019 OPERATING RESULTS.Q2 LOSS PER SHARE $0.32.Q2 REVENUE $76.3 MILLION VERSUS REFINITIV IBES ESTIMATE OF $70.2 MILLION.Q2 EARNINGS PER SHARE ESTIMATE $0.06 -- REFINITIV IBES DATA.Q2 ADJUSTED EARNINGS PER SHARE $0.35.SEES FY 2019 REVENUE $283 MILLION TO $293 MILLION.REVENUE FOR TRHC'S Q3 IN 2019 IS EXPECTED TO BE IN RANGE OF $74 MILLION TO $77 MILLION.SEES Q3 2019 NET LOSS IS EXPECTED TO BE IN RANGE OF $9.3 MILLION TO $8.5 MILLION.Q3 REVENUE VIEW $75.8 MILLION -- REFINITIV IBES DATA.FY2019 REVENUE VIEW $286.9 MILLION -- REFINITIV IBES DATA.

Tabula Rasa Healthcare Reports Qtrly Net Loss Per Diluted Share $0.54

May 8 (Reuters) - Tabula Rasa HealthCare Inc <TRHC.O>::TABULA RASA HEALTHCARE ANNOUNCES FIRST QUARTER 2019 OPERATING RESULTS.Q1 REVENUE $61 MILLION VERSUS REFINITIV IBES ESTIMATE OF $59.6 MILLION.SEES FY 2019 REVENUE $280 MILLION TO $290 MILLION.QTRLY NET LOSS PER DILUTED SHARE WAS $0.54.QTRLY NON-GAAP ADJUSTED NET INCOME PER DILUTED SHARE WAS $0.10.REVENUE FOR TRHC'S Q2 IN 2019 IS EXPECTED TO BE IN RANGE OF $68.0 MILLION TO $73.0 MILLION.Q2 NET LOSS IS EXPECTED TO BE IN RANGE OF $10.9 MILLION TO $10.1 MILLION.EXPECTS 2019 NET LOSS IN RANGE OF $39.3 MILLION TO $35.1 MILLION.

Tabula Rasa Healthcare Announces Acquisition Of Prescribewellness

March 5 (Reuters) - Tabula Rasa HealthCare Inc <TRHC.O>::TABULA RASA HEALTHCARE ANNOUNCES ACQUISITION OF PRESCRIBEWELLNESS EXPANDING ITS MEDICATION RISK MITIGATION OFFERING.TABULA RASA HEALTHCARE INC - PRESCRIBEWELLNESS CEO, AL BABBINGTON, WILL CONTINUE TO LEAD PW FOLLOWING ACQUISITION.

Marriott International Reports Fourth Quarter 2018 Results

Feb 28 (Reuters) - Marriott International Inc <MAR.O>::MARRIOTT INTERNATIONAL REPORTS FOURTH QUARTER 2018 RESULTS.Q4 ADJUSTED EARNINGS PER SHARE $1.44.Q4 EARNINGS PER SHARE $0.92.Q4 EARNINGS PER SHARE ESTIMATE $1.39 -- REFINITIV IBES DATA.MARRIOTT - EXPECT NORTH AMERICA REVPAR WILL INCREASE 1 TO 2 PERCENT IN Q1.MARRIOTT - FOR FULL YEAR 2019, WE EXPECT NORTH AMERICA AND WORLDWIDE REVPAR GROWTH OF 1 TO 3 PERCENT AND ROOMS GROWTH OF ROUGHLY 5.5 PERCENT, NET.MARRIOTT - Q4 2018 COMPARABLE SYSTEMWIDE CONSTANT DOLLAR REVPAR ROSE 1.3 PERCENT WORLDWIDE, 4.0 PERCENT OUTSIDE NORTH AMERICA AND 0.2 PERCENT IN NORTH AMERICA.MARRIOTT - MARRIOTT EXPECTS Q1 2019 ADJUSTED EBITDA COULD TOTAL $820 MILLION TO $845 MILLION.MARRIOTT - IN 2018 Q4, CO IDENTIFIED CERTAIN IMMATERIAL ERRORS RELATED TO LOYALTY PROGRAM ACCOUNTING.MARRIOTT - COMPANY WILL PROVIDE REVISED INFORMATION FOR EACH OF FIRST THREE QUARTERS OF 2018 IN ITS 2018 ANNUAL REPORT ON FORM 10-K ON MARCH 1, 2019.MARRIOTT - REVISED AMOUNTS WILL INCREASE NET INCOME BY $99 MILLION FOR FIRST THREE QUARTERS OF 2018 COMBINED.MARRIOTT - HAS ELECTED TO USE FULL RETROSPECTIVE METHOD IN ADOPTION OF NEW REVENUE STANDARD.MARRIOTT - IN Q1 OF 2019, COMPANY PLANS TO ADOPT ACCOUNTING STANDARDS UPDATE 2016-02.MARRIOTT - IMMATERIAL ERRORS IDENTIFIED IN Q4 RESULTED IN UNDERSTATEMENT OF COST REIMBURSEMENT REVENUE, NET OF REIMBURSED EXPENSES, IN FIRST 3 QTRS OF 2018.MARRIOTT - QTRLY TOTAL REVENUES, AS REPORTED, $5,289 MILLION VERSUS $5,251 MILLION.

Tabula Rasa Healthcare Inc - Co, Remedy Holdings Announced Agreement That Brings Trhc's Medication Therapy Management Technology To Canada

Feb 21 (Reuters) - Tabula Rasa HealthCare Inc <TRHC.O>::TABULA RASA HEALTHCARE EXPANDS MTM SOFTWARE REACH OUTSIDE THE UNITED STATES THROUGH A LICENSE TO A CANADIAN PHARMACY ORGANIZATION FOCUSED ON ENHANCING HEALTH OUTCOMES.TABULA RASA HEALTHCARE INC - CO, REMEDY HOLDINGS ANNOUNCED AGREEMENT THAT BRINGS TRHC'S MEDICATION THERAPY MANAGEMENT TECHNOLOGY TO CANADA.

Tabula Rasa Healthcare Announces Pricing Of $285 Mln Of 1.75 Pct Convertible Notes

Feb 8 (Reuters) - Tabula Rasa HealthCare Inc <TRHC.O>::TABULA RASA HEALTHCARE ANNOUNCES PRICING OF $285 MILLION OF 1.75% CONVERTIBLE NOTES.TABULA RASA HEALTHCARE INC - PRICING OF $285 MILLION PRINCIPAL AMOUNT OF 1.75% CONVERTIBLE SENIOR SUBORDINATED NOTES DUE 2026.TABULA RASA HEALTHCARE INC - SIZE OF OFFERING WAS INCREASED BY $35 MILLION FROM PREVIOUSLY ANNOUNCED OFFERING SIZE OF $250 MILLION.

金融情報はリフィニティブから。すべての情報は少なくとも20分遅れで表示されています。

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up